Can I read SGLT2 Inhibitors: Benefits and Risks on EtoBox?

SGLT2 Inhibitors: Benefits and Risks by ajjurajuthakur210204 is a document available to read on EtoBox.

What is SGLT2 Inhibitors: Benefits and Risks about?

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of diabetes medications that promote urinary glucose excretion, leading to decreased HbA1c, body weight, and blood pressure, while also reducing the risk of cardiovascular events and slowing kidney disease progression. However, they are associated with side effects such as genitourinary infections, ketoacidosis, and acute kidney injury. This review discusses the physiological mechanisms of SGLT2 inhibitors, their pharmacological effects, and

Author

ajjurajuthakur210204

Language

EN